Times Square Capital Management, LLC Argenx Se Transaction History
Times Square Capital Management, LLC
- $6.51 Billion
- Q4 2024
A detailed history of Times Square Capital Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Times Square Capital Management, LLC holds 124,245 shares of ARGX stock, worth $75.2 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
124,245
Previous 109,490
13.48%
Holding current value
$75.2 Million
Previous $59.4 Million
28.68%
% of portfolio
1.17%
Previous 0.91%
Shares
28 transactions
Others Institutions Holding ARGX
# of Institutions
435Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.34 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.86 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.4 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.08 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$749 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $33.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...